Survey on the Evaluation of Medication Information Leaflets for Organ Transplant Patients

Launched by UNIVERSITÄT MÜNSTER · Oct 19, 2024

Keywords

ClinConnect Summary

This clinical trial is looking to improve the information provided to organ transplant patients about their medications. Researchers want to hear from patients who have received a transplant (like a kidney, liver, heart, or lung) and from their caregivers or family members. By gathering feedback through a questionnaire, the study aims to make the medication information leaflets more helpful and easier to understand for people in this unique situation.

To participate in this study, you should be an adult who speaks German and has either had an organ transplant or is caring for someone who has. If you're under 18, unable to give consent, or no longer taking the necessary medications after a transplant, you won't be eligible. If you join, you can expect to share your thoughts on the information provided and help shape better resources for future patients and their families. This is an important opportunity to make sure that those who need this information can access it in a way that truly meets their needs.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients who have undergone solid organ transplantation (kidney, liver, heart, lung)
• • Caregivers or family members of organ transplant patients
• • German-speaking individuals
• • adult
• Exclusion Criteria:
• • Individuals who are not able to provide consent
• • Non-German-speaking individuals
• • under 18 years old
• • Patients who have undergone organ transplantation and are no longer taking immunosuppressants